We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+9.56%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$812M
AUM Growth
+$219M
(+37%)
Cap. Flow
+$173M
Cap. Flow
% of AUM
21.28%
Top 10 Holdings %
Top 10 Hldgs %
42.3%
Holding
3,095
New
215
Increased
1,249
Reduced
951
Closed
267
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$9.74M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.67M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$7.37M |
| 4 |
Apple
AAPL
|
+$6.37M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$5.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.33M |
| 2 |
MGI
MoneyGram International, Inc. New
MGI
|
+$1.19M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$774K |
| 4 |
FLG
Flagstar Bank National Association
FLG
|
+$531K |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$438K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.72% |
| 2 | Technology | 11.11% |
| 3 | Healthcare | 9.24% |
| 4 | Industrials | 3.53% |
| 5 | Consumer Staples | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Ameris Bancorp
ABCB
$5.89B
| $1.89K | ﹤0.01% |
40
| – | – |
|
|
PYCR
2252
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $1.88K | ﹤0.01% |
+77
| New | +$2.13K |
|
2253
Castle Biosciences
CSTL
$979M
| $1.88K | ﹤0.01% |
80
-61
| -43% | -$1.41K |
|
|
HDSN
2254
Hudson Technologies
HDSN
$235M
| $1.88K | ﹤0.01% |
186
| – | – |
|
2255
CareTrust REIT
CTRE
$9.74B
| $1.88K | ﹤0.01% |
101
-92
| -48% | -$1.72K |
|
2256
Vir Biotechnology
VIR
$1.49B
| $1.87K | ﹤0.01% |
74
-169
| -70% | -$4.14K |
|
2257
Fidelity High Dividend ETF
FDVV
$10.5B
| $1.86K | ﹤0.01% |
50
| – | – |
|
2258
Freedom Holding
FRHC
$9.49B
| $1.86K | ﹤0.01% |
+32
| New | +$1.84K |
|
2259
Western Digital
WDC
$150B
| $1.86K | ﹤0.01% |
78
-109
| -58% | -$2.88K |
|
|
SGI
2260
Somnigroup International
SGI
$13.7B
| $1.85K | ﹤0.01% |
54
+20
| +59% | +$602 |
|
2261
Medifast
MED
$141M
| $1.85K | ﹤0.01% |
16
-54
| -77% | -$6.29K |
|
2262
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
| $1.85K | ﹤0.01% |
56
-145
| -72% | -$4.7K |
|
2263
TFS Financial
TFSL
$4.93B
| $1.84K | ﹤0.01% |
128
+92
| +256% | +$1.26K |
|
2264
Cannae Holdings
CNNE
$649M
| $1.84K | ﹤0.01% |
89
+57
| +178% | +$1.25K |
|
|
CHS
2265
DELISTED
Chicos FAS, Inc.
CHS
| $1.83K | ﹤0.01% |
373
| – | – |
|
2266
Certara
CERT
$1.25B
| $1.83K | ﹤0.01% |
114
+96
| +533% | +$1.39K |
|
2267
Navient
NAVI
$853M
| $1.83K | ﹤0.01% |
+111
| New | +$1.76K |
|
2268
Keros Therapeutics
KROS
$221M
| $1.82K | ﹤0.01% |
38
+21
| +124% | +$981 |
|
|
INBX
2269
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.82K | ﹤0.01% |
74
+33
| +80% | +$970 |
|
2270
Clarivate
CLVT
$1.16B
| $1.82K | ﹤0.01% |
218
+179
| +459% | +$1.68K |
|
|
BASE
2271
DELISTED
Couchbase
BASE
| $1.82K | ﹤0.01% |
137
+44
| +47% | +$570 |
|
2272
Enanta Pharmaceuticals
ENTA
$400M
| $1.81K | ﹤0.01% |
39
+26
| +200% | +$1.19K |
|
2273
MaxLinear
MXL
$6.8B
| $1.8K | ﹤0.01% |
53
-5
| -9% | -$169 |
|
2274
TIM SA
TIMB
$8.8B
| $1.79K | ﹤0.01% |
154
+118
| +328% | +$1.43K |
|
2275
Phathom Pharmaceuticals
PHAT
$692M
| $1.78K | ﹤0.01% |
159
-14
| -8% | -$144 |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Lindbrook Capital held 3,095 positions worth $812M, up 37% from $593M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Lindbrook Capital deployed $173M of net new capital in Q4 2022, opening 215 new positions and adding to 1,249 existing holdings. Its largest new stake was Invesco DB Commodity Index Tracking Fund: 184,095 shares worth $4.54M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Russell 1000 Growth ETF, an estimated $1.33M trimmed.
- Lindbrook Capital's largest Q4 2022 buy was Invesco DB Commodity Index Tracking Fund: 184,095 shares worth $4.54M.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q4 2022, an estimated $9.74M increase.
- Lindbrook Capital's biggest Q4 2022 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $1.33M.
- Lindbrook Capital fully exited iShares ESG Aware MSCI USA ETF in Q4 2022, selling an estimated $215K.
- Lindbrook Capital's ten largest holdings make up 42% of its $812M portfolio in Q4 2022.
- Lindbrook Capital opened 215 new positions and closed 267 in Q4 2022.
- Lindbrook Capital's portfolio value rose 37% quarter-over-quarter to $812M.
Based on Lindbrook Capital's 13F filing for Q4 2022, filed 25 Jan 2023.